Charles River Laboratories International (CRL) Revenue (2009 - 2025)

Charles River Laboratories International (CRL) has reported Revenue for 17 consecutive years, with $994.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Revenue fell 0.83% year-over-year to $994.2 million; the TTM figure through Dec 2025 stood at $4.0 billion (down 0.85% YoY), while the FY2025 annual figure was $4.0 billion, down 0.85% from the prior year.
• Revenue came in at $994.2 million for Q4 2025 at Charles River Laboratories International, down from $1.0 billion in the prior quarter.
• The five-year high for Revenue was $1.1 billion in Q4 2022, with the low at $824.6 million in Q1 2021.
• Average Revenue over 5 years is $985.6 million, with a median of $1.0 billion recorded in 2024.
• Across the five-year window, Revenue surged 33.99% in 2021 and decreased 7.85% in 2023, its largest moves.
• Year by year, Revenue stood at $905.0 million in 2021, then grew by 21.52% to $1.1 billion in 2022, then slipped by 7.85% to $1.0 billion in 2023, then retreated by 1.08% to $1.0 billion in 2024, then retreated by 0.83% to $994.2 million in 2025.
• According to Business Quant data, Revenue over the past three periods registered $994.2 million, $1.0 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.